JPMorgan has released a report predicting that China's healthcare expenditure will increase by 1.7 times to USD2.4 trillion over the next decade with the rapid development of the country's aging society trend.The report stressed that China's recent policies are encouraging insurance products for the elderly and those with pre-existing health conditions, which will help unlock potential growth opportunities.Related NewsCICC Lists HK Stocks w/ Largest QoQ Gains in Holdings by CN Actively Managed Equity Funds (Table)According to the trend, China's healthcare services market, including traditional Chinese medicine and ophthalmology, will continue to expand. Even though there was a period of weak demand earlier, the broker expects recovery to begin this year. In contrast, the dental industry still faces weak demand and policy uncertainties.JPMorgan believes that the main beneficiaries of the aforementioned trends will include GUSHENGTANG (02273.HK) -0.550 (-1.475%) Short selling $5.33M; Ratio 8.664% , PING AN (02318.HK) -0.500 (-0.903%) Short selling $866.24M; Ratio 21.217% , and PICC P&C (02328.HK) -0.100 (-0.613%) Short selling $109.63M; Ratio 17.327% .(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-24 16:25.)